SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001615219-24-000030
Filing Date
2024-03-26
Accepted
2024-03-26 16:03:35
Documents
3
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 DEF 14A slrx-2023proxystatementspe.htm DEF 14A 214548
2 screenshot2024-03x25152920a.gif GRAPHIC 73423
3 screenshot2024-03x25153214a.jpg GRAPHIC 205069
  Complete submission text file 0001615219-24-000030.txt   599554
Mailing Address 2450 HOLCOMBE BLVD SUITE J-608 HOUSTON TX 77021
Business Address 2450 HOLCOMBE BLVD SUITE J-608 HOUSTON TX 77021 346-772-0346
Salarius Pharmaceuticals, Inc. (Filer) CIK: 0001615219 (see all company filings)

IRS No.: 465087339 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36812 | Film No.: 24783483
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)